Vise Technologies Inc. Takes $308,000 Position in Dolby Laboratories, Inc. (NYSE:DLB)

Vise Technologies Inc. purchased a new position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,942 shares of the electronics maker's stock, valued at approximately $308,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DLB. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Dolby Laboratories by 3.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 225,618 shares of the electronics maker's stock worth $17,621,000 after purchasing an additional 6,640 shares in the last quarter. Squarepoint Ops LLC boosted its stake in Dolby Laboratories by 247.2% during the fourth quarter. Squarepoint Ops LLC now owns 191,675 shares of the electronics maker's stock valued at $14,970,000 after buying an additional 136,465 shares during the last quarter. Two Sigma Advisers LP boosted its stake in Dolby Laboratories by 20.4% during the fourth quarter. Two Sigma Advisers LP now owns 29,500 shares of the electronics maker's stock valued at $2,304,000 after buying an additional 5,000 shares during the last quarter. Teza Capital Management LLC bought a new position in Dolby Laboratories during the fourth quarter valued at approximately $588,000. Finally, State of Wyoming boosted its stake in Dolby Laboratories by 110.1% during the fourth quarter. State of Wyoming now owns 6,410 shares of the electronics maker's stock valued at $501,000 after buying an additional 3,359 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 675 shares of Dolby Laboratories stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $75.04, for a total transaction of $50,652.00. Following the completion of the sale, the senior vice president now owns 121,151 shares of the company's stock, valued at approximately $9,091,171.04. The trade was a 0.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 38.39% of the company's stock.

Dolby Laboratories Stock Performance

DLB traded down $0.76 during trading on Friday, hitting $74.24. 578,123 shares of the stock were exchanged, compared to its average volume of 453,282. The firm has a 50 day simple moving average of $75.32 and a 200 day simple moving average of $78.62. The firm has a market cap of $7.13 billion, a price-to-earnings ratio of 27.29 and a beta of 0.95. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.29 by $0.05. The business had revenue of $369.56 million for the quarter, compared to the consensus estimate of $375.44 million. Dolby Laboratories had a return on equity of 11.32% and a net margin of 19.97%. The business's revenue was up 1.4% compared to the same quarter last year. During the same period last year, the business posted $1.27 EPS. As a group, equities analysts anticipate that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 21st. Stockholders of record on Tuesday, May 13th were given a $0.33 dividend. The ex-dividend date was Tuesday, May 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.78%. Dolby Laboratories's payout ratio is 49.81%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on DLB shares. Tigress Financial started coverage on Dolby Laboratories in a research note on Thursday, May 15th. They set a "buy" rating and a $112.00 price target for the company. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Friday. Rosenblatt Securities lowered their price objective on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Finally, Barrington Research reissued an "outperform" rating and set a $100.00 price target on shares of Dolby Laboratories in a research note on Friday, May 2nd.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.